Moderna (MRNA) Equity Ratio (2017 - 2025)
Historic Equity Ratio for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to 0.77.
- Moderna's Equity Ratio rose 187.09% to 0.77 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77, marking a year-over-year increase of 187.09%. This contributed to the annual value of 0.77 for FY2024, which is 252.07% up from last year.
- Moderna's Equity Ratio amounted to 0.77 in Q3 2025, which was up 187.09% from 0.78 recorded in Q2 2025.
- In the past 5 years, Moderna's Equity Ratio registered a high of 0.79 during Q1 2025, and its lowest value of 0.3 during Q1 2021.
- In the last 5 years, Moderna's Equity Ratio had a median value of 0.75 in 2024 and averaged 0.68.
- As far as peak fluctuations go, Moderna's Equity Ratio plummeted by 6190.64% in 2021, and later surged by 10455.19% in 2022.
- Quarter analysis of 5 years shows Moderna's Equity Ratio stood at 0.57 in 2021, then increased by 28.98% to 0.74 in 2022, then increased by 1.67% to 0.75 in 2023, then increased by 2.52% to 0.77 in 2024, then fell by 0.26% to 0.77 in 2025.
- Its Equity Ratio was 0.77 in Q3 2025, compared to 0.78 in Q2 2025 and 0.79 in Q1 2025.